Complexa

Complexa Inc. is a clinical biopharmaceutical company dedicated to transforming the lives of patients with severe and life-threatening fibrotic and inflammatory diseases. The company is developing drugs designed to prevent and repair tissue damage as well as reverse fibrosis and inflammation. Their focus is on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), both of which are rare diseases that impair the normal function of the kidneys and heart.